Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma diagnosed between 2008 and 2012

导出原文传递

翻译打印收藏纠错

作者： Dinan, Michaela A. ^[1] ; Georgieva, Mihaela, V ^[2] ; Li, Yanhong ^[3] ; Zhang, Tian ; Harrison, Michael ; Shenolikar, Rahul ; Scales, Charles D., Jr.

作者单位： AstraZeneca, Gaithersburg, MD USA ^[1] Duke Clin Res Inst, DUMC 3707, Durham, NC 27710 USA ^[2] Duke Canc Inst, Durham, NC USA ^[3]

关键词 First-line treatment Real-world Second-line treatment Treatment patterns Urothelial carcinoma

发布时间 2021-07-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Journal of geriatric oncology

2021年12卷2期

298-304页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma diagnosed between 2008 and 2012

Journal of geriatric oncology

相似文献

Journal of geriatric oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma diagnosed between 2008 and 2012

Journal of geriatric oncology

相似文献

Journal of geriatric oncology

相关期刊

检索历史清除